Friday, January 15, 2016
Hunt Valley, MD —Sheridan was recently awarded editorial services and print production for two journal titles of the American Society of Clinical Oncology, Inc. (ASCO®), the world’s leading professional organization representing physicians who care for people with cancer, as well as 14 of ASCO®’s meeting publications, beginning in January 2016.
Editorial services for ASCO’s Journal of Clinical Oncology will be handled by Sheridan Journal Services, and print production will be done by Sheridan’s New Hampshire printing facility. This journal is published 36 times a year, in print and electronic format.
Journal of Global Oncology is a new online-only, open access publication to publish six times yearly and Sheridan Journal Services will provide full front-end service.
ASCO’s 14 meeting publications will be printed at Sheridan’s Pennsylvania facility, and Sheridan Journal Services will handle editorial services and XML for several of them.
Sheridan front-end services include conversion, copyediting and figures assignments, figure editing and branding, copyediting, and Sheridan’s patent-pending web-based proofing environment, ArticleExpress™. Upon implementation of the ArticleExpress proofing system, authors submitting work to ASCO publications will have the ability to correct proofs in a user-friendly, word-like environment while preserving the XML workflow, and dramatically reducing cycle time to approved article submission.
Managing Director of Sheridan Journal Services Gary Kittredge said, “ASCO publications represent the highest level of oncological research and information in the industry. We are gratified to be chosen to assist in the preparation and distribution of their content, and very happy that ASCO will benefit from our unique XML-based ArticleExpress™ automated proofing environment.”
Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization representing physicians who care for people with cancer. With more than 35,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org.
ASCO® is a registered trademark of the American Society of Clinical Oncology. ® Used with permission. ASCO® is not a partner or affiliate of Sheridan and does not recommend or endorse any vendor, product, or service.
Sheridan is a leading provider of print, publishing services and technology solutions to publishers, associations, university presses, and catalogers. With four U.S. based-production facilities, each location has a market specialty that supports STM and commercial reprints, scholarly journals, magazines, catalogs, or books. www.sheridan.com.